It depends on the medical history, current treatment plan and diagnosis of the patient. For example, we may recommend somatic testing, including large panel testing that specifically looks for clinically actionable genes within the cancer DNA. These tests may include a liquid biopsy, tumor tissue sequencing, companion diagnostics or complementary diagnostics. Or if there is a history of cancer in the patients family we may recommend germline testing for risk assessment and preventative care. The lab testing space has grown drastically and there are a number of testing options available. We will help navigate through the testing options based on the patient’s needs.